Study details
Enrolling now
Optimizing Therapy in Epilepsy Using Seizure Forecasts Via EEG and Wearables
Mayo Clinic
NCT IDNCT07012148ClinicalTrials.gov data as of Apr 2026
Target enrollment
12
Study length
about 4 years
Ages
18–75
Locations
1 site in MN
What this study is about
This trial is testing a new device, UNEEG SubQ, to predict seizures based on brain activity. The goal is to see if this device can help people with epilepsy manage their condition.
Simplified from trial records by PatientMatch.
What you may be asked to do
- 1.Receive UNEEG SubQ device
Participation Burden
What's physically and logistically required of participants.
Logistics & Travel
In-person visits
Requires travel to a study site
Physical Intervention
Standard
How treatment is administered
Treatment Assignment
All receive treatment
Everyone gets the investigational treatment.
Extracted study details
Pulled from the trial record to show what is being tested and what the study is measuring.
Endpoints
Primary: Safety and Adverse Events, Surgical and Device related adverse events
Secondary: Quality of Life Inventory
Body systems
Neurology